Short answer: the abdomen, the thigh or the upper arm, and you do not have to switch between them
Ozempic is injected under the skin in the abdomen, the thigh or the upper arm. No fourth area is approved and no one of the three works better than the others. The part nearly every page gets slightly wrong is the rotation instruction. The label does not tell you to move from stomach to thigh to arm week by week. It says to use a different injection site each week when injecting in the same body region, which is an instruction to move the spot, not the region. One Ozempic pen holds four weekly doses, so a single pen is a natural four week block of four different spots inside one area.
The pages currently ranking for this question agree on the three areas and then diverge on everything that follows. One adds the buttocks as a fourth area. Several give measurements in inches that do not appear in any Ozempic document. Most describe rotation as a weekly tour of the body. This page works from the Ozempic prescribing information revised in May 2026, quotes the sentences that settle each point, and says plainly where the label is silent.
The sentence in section 2.1, in full
Under Important Administration Instructions, the label gives two lines about where the injection goes:
"Inject OZEMPIC subcutaneously in the abdomen, thigh, or upper arm. Instruct patients to use a different injection site each week when injecting in the same body region."
"When using OZEMPIC with insulin, instruct patients to administer as separate injections and never mix the products. It is acceptable to inject OZEMPIC and insulin in the same body region, but the injections should not be adjacent to each other."
Read the first one carefully. The conditional clause is doing real work. "When injecting in the same body region" presumes that staying in one region is a normal thing to do, and it attaches the requirement to what you do inside that region. Nothing in the Ozempic label asks you to visit all three areas on a schedule.
The Medication Guide, written for patients rather than prescribers, states it more broadly: "Change (rotate) your injection site with each injection. Do not use the same site for each injection." That is the same requirement without the regional framing. Both sentences are satisfied by the same behaviour: a new spot every week.
The same molecule, a different rotation sentence
Semaglutide is sold as Ozempic and as Wegovy. Both labels cover the same drug, and both are Novo Nordisk documents, but they do not word the rotation instruction the same way.
| Document | What it says about rotation | What that permits |
|---|---|---|
| Ozempic prescribing information, section 2.1 | "Use a different injection site each week when injecting in the same body region." | Stay in one region, change the spot weekly. |
| Wegovy prescribing information, section 2.1 | "Rotate injection sites with each dose." | Change the site weekly. Region not specified. |
| Wegovy FlexTouch Instructions for Use | "You may inject in the same body area each week, but make sure it is not in the same spot used for the last injection." | Explicit permission to stay in one area. |
The third row is the clearest statement any of these documents makes, and it points the same way as the Ozempic sentence. Staying in one area is allowed. Reusing the exact spot is not.
Your pen tells you how many spots you need
Ozempic pens are multi-dose. Section 3 of the label lists what each one holds, and the carton ships with a matching number of needles, which is a quietly useful fact: the needle count is the injection count.
| Pen | Doses in the pen | Needles in the carton | Weeks it covers |
|---|---|---|---|
| 2 mg / 3 mL | 4 doses of 0.25 mg and 2 doses of 0.5 mg, or 4 doses of 0.5 mg | 6 | 6 weeks, or 4 |
| 4 mg / 3 mL | 4 doses of 1 mg | 4 | 4 weeks |
| 8 mg / 3 mL | 4 doses of 2 mg | 4 | 4 weeks |
| Single-dose prefilled syringe | 1 dose of 0.25 mg, 0.5 mg or 1 mg | Integrated | 1 week |
That gives you a cleaner unit of planning than the calendar does. A maintenance pen is four injections. If you want a rotation scheme you will actually keep to, make the pen the block.
A four spot cycle that matches the pen
Nothing below is a medical instruction. It is a way of satisfying the label's sentence without having to remember anything.
- Pick one region for the life of the pen. The abdomen is the usual choice because you can see it and reach it with either hand.
- Divide it into four spots. In the abdomen, the four quadrants around the navel work: upper left, upper right, lower left, lower right. Keep well clear of the navel itself.
- Use one spot per dose, in the same order every pen. Four doses, four spots, one pen.
- When the pen is empty, move region if you want to. Or do not. The label does not require it, and the next pen restarts the same four spots with four weeks of recovery behind each one.
The upper arm is the one area worth a note. On the semaglutide labels the upper arm is an injection area like the others, with no instruction that someone else has to do it. That is not true across the class: the tirzepatide labels tell you to have another person inject the back of the upper arm. If you are coming to Ozempic from Mounjaro or Zepbound, you gain a self-injection area. Our guide to the best GLP-1 injection site for weight loss sets the four labels side by side on exactly this point.
The number that puts rotation in proportion
Rotation gets written about as though it were holding back something common. On Ozempic it is not. Section 6.1 reports:
"In placebo-controlled trials, injection site reactions (e.g., injection-site discomfort, erythema) were reported in 0.2% of OZEMPIC-treated patients."
Two in a thousand. For comparison, the Wegovy label reports 1.4 percent against 1 percent on placebo in adult weight-reduction trials, and the Zepbound label reports 6 to 8 percent by dose against 2 percent on placebo. Same category of medicine, a thirtyfold spread in how often the skin complains.
This is worth knowing for two reasons. It means rotation on Ozempic is cheap insurance rather than urgent damage control. And it means that if you are getting a reaction at every site on Ozempic, that is unusual enough to mention to your prescriber rather than to treat as the normal cost of the drug.
Why you cannot tell from how you feel whether the site was right
Section 12.3 gives three numbers that between them close off the question:
- Absolute bioavailability is 89 percent. Almost all of a subcutaneous dose reaches circulation.
- Maximum concentration is reached 1 to 3 days post dose. Whatever you feel in the first hours is not peak drug level.
- Steady state is reached after 4 to 5 weeks of once-weekly dosing. Levels are still climbing across your first pen.
And the sentence that answers the "which site is best" question directly: "Similar exposure is achieved with subcutaneous administration of semaglutide in the abdomen, thigh, or upper arm." Similar exposure means the same amount of drug in your blood. There is no absorption advantage to trade off against comfort, so comfort can simply decide.
What to avoid, and what the label does not actually say to avoid
The label's own restrictions are short. Do not use the pen if particulate matter or discoloration is seen. Do not mix with insulin in the same injection, and keep the two injections non-adjacent if they share a region. The Instructions for Use adds the practical steps: choose your site, wipe the skin with an alcohol swab, and let it dry before injecting.
Three things widely repeated about Ozempic sites are not in the US label at all:
- The buttocks. At least one page ranking for this query lists the buttocks as a recommended area. The US Ozempic label names three areas and that is not one of them.
- A 2 inch clearance from the navel. This is real, but it comes from the Wegovy Instructions for Use, which says to keep 2 inches (5 cm) from the belly button. The Ozempic documents do not state a distance. Treating it as sensible practice is fine. Citing it to the Ozempic label is not.
- Precise thigh boundaries in inches. Figures like "4 inches above the knee to 4 inches below the hip" appear on several ranking pages and in no Novo Nordisk document for this product.
None of those three is dangerous. They are repeated confidently enough that it is worth knowing which ones you can actually look up.
If you take insulin as well
This is the one genuinely technical point in section 2.1 and most site guides skip it. Ozempic and insulin are given as separate injections and are never mixed in a syringe. They may go in the same body region on the same day, but the two injections must not be adjacent to each other. If you are running both, your rotation plan has to track two injection streams in one region rather than one, which is where writing it down stops being optional.
Keeping the four week count without keeping it in your head
A four spot cycle fails in exactly one place: week three, when you are no longer sure whether you did the upper left last time or two weeks ago. That is not a memory problem worth solving with effort. It is a record problem.
Jabby logs each dose against the spot you used on a body map, so the next spot is the one the app shows you rather than the one you half remember. It also keeps any skin reaction attached to the dose and the spot it followed, which is the only way to tell later whether a reaction tracks one area or arrived with a dose increase. If you want the wider picture of what a tracker does across a GLP-1 course, our GLP-1 tracker app overview covers it.
Four doses in a pen, four spots, no guessing
Log the dose and the site together, and the rotation keeps itself.
Download Jabby - Free on App StoreFrequently asked questions
Where do you inject Ozempic?
Subcutaneously in the abdomen, the thigh or the upper arm. Section 2.1 of the US prescribing information lists those three and names no fourth area and no preferred one.
Can you inject Ozempic in the buttocks?
The US Ozempic label does not list the buttocks. Some pages ranking for this question add it, which appears to be carried over from general subcutaneous injection advice rather than from this product's labelling.
Do you have to change body areas every week?
No. The label asks you to use a different injection site each week when injecting in the same body region. Staying in the abdomen and moving the spot satisfies it, and the Wegovy FlexTouch Instructions for Use says so explicitly for the same molecule.
How common are Ozempic injection site reactions?
0.2 percent of Ozempic-treated patients in placebo-controlled trials, per section 6.1. That is low enough that a repeated reaction is worth raising with your prescriber rather than absorbing.
Does the injection site change how well Ozempic works?
No. Section 12.3 states that similar exposure is achieved in the abdomen, thigh or upper arm.
What if I miss a dose?
Section 2.1 says to administer it as soon as possible within 5 days of the missed dose, and if more than 5 days have passed, to skip it and take the next dose on the regular day. The day of the week can be changed as long as at least 48 hours separate two doses. Anything beyond that is a question for your prescriber.
Related reading
- Best GLP-1 injection site for weight loss, which sets all four US labels against each other.
- Wegovy injection sites, drawn from the label, for the same molecule at a weight-management dose.
- Ozempic vs Wegovy, on what separates the two semaglutide products.
- Best injection sites for Mounjaro, where the upper arm rule is different.
- GLP-1 tracker app overview.
Sources
- OZEMPIC (semaglutide) injection US prescribing information, Novo Nordisk, revised 05/2026. Sections 2.1, 3, 6.1, 12.3, 16, plus the Medication Guide and Instructions for Use.
- WEGOVY (semaglutide) US prescribing information, Novo Nordisk. Section 2.1 and 6.1, and the Instructions for Use for the single-dose pen and for WEGOVY FlexTouch.
- MOUNJARO (tirzepatide) US prescribing information, Eli Lilly and Company, revised 08/2026. Section 2.2, for the upper arm comparison.
- ZEPBOUND (tirzepatide) US prescribing information, Eli Lilly and Company, revised 08/2026. Section 6.1, for the injection site reaction comparison.
- Ozempic label on DailyMed, US National Library of Medicine.
This page summarises published prescribing information for general education. It is not medical advice and contains no dosing guidance. Where to inject, how much to inject and whether a medicine suits you are decisions for the clinician who prescribed it. Follow the Instructions for Use supplied with your own device.
Jabby is free on the App Store and keeps your dose history, site rotation and side effects in one record you can show your prescriber.